1639-巨噬细胞调控克服三阴性乳腺癌PARP抑制剂耐药 episode artwork

EPISODE · Oct 3, 2026 · 23 MIN

1639-巨噬细胞调控克服三阴性乳腺癌PARP抑制剂耐药

from 聊聊Sci

这篇文章探讨了在BRCA基因突变引起的三阴性乳腺癌(TNBC)中,PARP抑制剂如何通过复杂的代谢重编程影响肿瘤巨噬细胞。研究发现,虽然此类药物能激活抗肿瘤免疫,但同时也会诱导巨噬细胞产生免疫抑制性特征,导致治疗耐药。通过单细胞分析和实验验证,作者证实了巨噬细胞是这类肿瘤中主要的浸润免疫细胞,且其表型变化具有PARP1依赖性。为了克服这一瓶颈,研究提出将PARP抑制剂与CSF1R阻断抗体联合使用。这种组合疗法在小鼠模型中成功重塑了肿瘤微环境,增强了T细胞的抗癌效力,并显著延长了生存期,为临床治疗提供了新策略。References:Mehta A K, Cheney E M, Hartl C A, et al. Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer[J]. Nature cancer, 2021, 2(1): 66-82.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Oct 3, 2026

Embed this episode

Ready to play

1639-巨噬细胞调控克服三阴性乳腺癌PARP抑制剂耐药

0:00 23:04

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 23 minutes long.

When was this 聊聊Sci episode published?

This episode was published on October 3, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!